Blood test may predict Behçet's flare-ups
NCT ID NCT06729112
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study looked at whether a new blood test called the pan-immune-inflammation value (PIN) can help measure disease activity in people with Behçet's syndrome. Researchers compared 80 Behçet's patients to healthy controls. The goal is to find a simple, non-invasive way to monitor this complex inflammatory disease.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- What this could lead to
- If successful, this could provide doctors with a simple blood test to help monitor Behçet's disease activity and guide treatment decisions.
- What could go wrong
- This is a small, completed observational study, not a treatment trial. The PIN value needs much larger validation before it could be used in routine care.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
80 people
The number who actually took part.
- Started
-
Dec 2023
- Finished
-
Mar 2025
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Adult BD patients who fulfilling the criteria for the diagnosis by International Team for the Revision of the International Criteria for Bechet's Disease attending Rheumatology, Rehabilitation and Physical Medicine Department, Assiut University Hospitals.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Adult BD patients who fulfilling the criteria for the diagnosis by International Team for the Revision of the International Criteria for Bechet's Disease . * Accept to participate in the current study. Exclusion Criteria: * Individuals with other autoimmune diseases. * Patients unwilling to participate in the study. * Patients less than 18 years old. * Patients with malignancy or infections. * Pregnancy and lactation
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Behcet syndrome are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Assiut University Hospitals
Asyut, 71111, Egypt
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Gum fluid holds clues to Behçet's disease puzzle
- New protein clue may help track Behcet's disease activity
- Landmark study questions blood thinner use in Behçet's clots
- Behçet's disease: hidden mental toll revealed in new study
- New study aims to uncover hidden health impacts of rare blood vessel diseases
- New pill shows promise for rare inflammatory disease